Theodore R. Schroeder's most recent trade in Phathom Pharmaceuticals Inc was a trade of 24,122 Common Stock done . Disclosure was reported to the exchange on May 19, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phathom Pharma Inc | Theodore R. Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2026 | 24,122 | 45,122 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 20,500 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 11,100 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 2,125 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 2,125 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 1,400 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 875 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 875 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 550 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 550 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 550 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Jan 2026 | 450 | 0 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 11,100 | 11,100 | - | - | Stock Option (right to buy) | |
| Phathom Pharma Inc | Theodore R. Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2025 | 35,000 | 35,000 | - | - | Common Stock (Right to Buy) | |
| Phathom Pharma Inc | Theodore R. Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2025 | 21,000 | 21,000 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Schroeder R. Theodore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2024 | 20,500 | 20,500 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 2,125 | 2,125 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 42,500 | 42,500 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Theodore R. Schroeder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 28,000 | 28,000 | - | - | Stock Option (right to buy) |